Clinical Trials Browser

Phase 1/2 × Malignant Solid Tumor × Nivolumab × Clear all

NCT02754141 2023-04-05

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

Phase 1/2 Completed

235 enrolled 37 charts

Other solid neoplasm

Malignant Solid Tumor